Stay updated on Pembrolizumab Trastuzumab Chemotherapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Trastuzumab Chemotherapy Clinical Trial page.

Latest updates to the Pembrolizumab Trastuzumab Chemotherapy Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s footer/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor system release rather than a modification to the clinical trial details.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedSite framework updated from v3.4.3 to v3.5.0. This change appears to be an internal upgrade with no impact on study details or user workflows.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed to reflect a page version update.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded the condition Gastric cancer and a new Resources link to the Genetic and Rare Diseases Information Center. Removed the government funding lapse notice and the older revision (v3.4.1); updated revision to v3.4.2.SummaryDifference0.5%

- Check92 days agoChange DetectedThe update includes a site-wide notice about government funding and the NIH Clinical Center's status, along with a version bump from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Trastuzumab Chemotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Trastuzumab Chemotherapy Clinical Trial page.